Jason L. Weirather
- Immunology top 5%
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 5
- Cancer Research top 10%
- Parasitology top 10%
-
- Research on Leishmaniasis Studies 5
-
- Lymphoma Diagnosis and Treatment 5
-
- RNA modifications and cancer 4
-
- Trypanosoma species research and implications 4
- Co-authors
- Scott J. RodigKin Fai AuMary E. WilsonF. Stephen HodiAnita Giobbie‐HurderShyam SundarAnna C. PavlickChristine E. Horak
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesBrazilUnited Kingdom
In The Last Decade
Jason L. Weirather
33 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Immunology 466
- Oncology 600
- Cancer Research 172
- Parasitology 63
- Public Health, Environmental and Occupational Health 274
Countries citing papers authored by Jason L. Weirather
This map shows the geographic impact of Jason L. Weirather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason L. Weirather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason L. Weirather more than expected).
Fields of papers citing papers by Jason L. Weirather
This network shows the impact of papers produced by Jason L. Weirather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason L. Weirather. The network helps show where Jason L. Weirather may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jason L. Weirather, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 17 | |
| 3 | 2024 | 16 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 88 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 28 | |
| 11 | MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanomabreakdown → | 2018 | 408 |
| 12 | 2018 | 16 | |
| 13 | 2016 | 5 | |
| 14 | 2015 | 18 | |
| 15 | 2015 | 80 | |
| 16 | 2012 | 5 | |
| 17 | 2012 | 43 | |
| 18 | 2012 | 98 | |
| 19 | 2011 | 10 | |
| 20 | 2011 | 10 |
About Jason L. Weirather
Jason L. Weirather is a scholar working on Oncology, Internal Medicine and Immunology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (5 papers), Research on Leishmaniasis Studies (5 papers), Immunotherapy and Immune Responses (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers), RNA modifications and cancer (4 papers) and Trypanosoma species research and implications (4 papers). The work is most often cited by research in Immunology (466 citations), Oncology (600 citations) and Cancer Research (172 citations). Jason L. Weirather has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Scott J. Rodig, Kin Fai Au, Mary E. Wilson, F. Stephen Hodi, Anita Giobbie‐Hurder, Shyam Sundar, Anna C. Pavlick, Christine E. Horak, Donald Jackson and Han Chang. Their work appears in journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.